StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research report released on Sunday morning. The firm issued a sell rating on the stock.
Navidea Biopharmaceuticals Price Performance
Shares of Navidea Biopharmaceuticals stock opened at $0.04 on Friday. Navidea Biopharmaceuticals has a 1 year low of $0.02 and a 1 year high of $0.28. The company has a market capitalization of $3.68 million, a P/E ratio of -0.61 and a beta of 1.13. The business has a 50 day moving average price of $0.04 and a 200 day moving average price of $0.05.
Navidea Biopharmaceuticals Company Profile
Featured Articles
- Five stocks we like better than Navidea Biopharmaceuticals
- How to Evaluate a Stock Before BuyingÂ
- Charles Schwab Fortifies its Uptrend on EPS Beat
- What is the S&P 500 and How It is Distinct from Other Indexes
- Lockheed Martin Stock Aims for a Fresh All-Time High
- There Are Different Types of Stock To Invest In
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Navidea Biopharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Navidea Biopharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.